The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it ...
Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD (mild cognitive impairment due to ...